$4450 | Single User
$8900 | Site License
$11645 | Enterprise License

Point of Care Diagnostics - US Analysis and Market Forecasts
[Lowest Price Guaranteed: $4,450]

Published by Global Data: 01 Mar 2016 | 27850 | In Stock

Introduction

Point of Care Diagnostics - US Analysis and Market Forecasts

Summary

The US Point-Of-Care (POC) diagnostics market is a dynamic market that is expected to grow through 2021. In the US, economic softness and reforming healthcare expenditures has impacted the adoption rate of POC devices in decentralized settings; the POC market is posting conservative growth in the US. The driving concept in sustenance of POC testing is to bring testing nearer to the patient and results swiftly to the physician to accelerate diagnosis and subsequent treatment. POC testing allows for faster clinical decisions in emergency departments, physicians’ offices, ambulances, patient homes, and in the field. Because of its convenience, and potential to reduce hospital time stay, testing at POC has risen in popularity in recent years in the US.

A number of factors, such as the rising incidences of lifestyle diseases such as cardiac diseases and diabetes, the rising usage of home-based POC devices, expansion of test menu, and technological advancements in molecular testing and lab-on-chip technology are stimulating the demand for POC testing. While POC testing is one of the most active segments within the in-vitro diagnostics (IVD) industry, the rate of POC testing adoption will be moderated by the requirement for regulatory compliance, the pressure to control cost, and the need to demonstrate clear clinical-cost benefits of POC testing over central laboratory testing. Moving forward, in light of increasing demand for POC testing, manufacturing companies are racing to make the next-generation POC platforms faster, easier, and more reliable.

This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed and pipeline products, current and emerging players, as well as market outlooks in the US. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions in using and evaluating the adoption of different types of POC devices.

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.

Highlights

Key Questions Answered

- What is the current and future POC diagnostics market outlook in the US? What trends are affecting the US market?

- What is the competitive landscape and market share of major players in the POC space in the US?

- What are the key, high growth markets that IVD manufacturers should expand into? Which market segments are growing the fastest?

- What are the unmet needs with the POC tests currently on the market? How will emerging technologies such as molecular POC assays fulfill these unmet needs?

- What are the key factors influencing a physician to use POC tests? What is physician perception and market outlook of POC devices?

- What are the challenges and barriers that have hindered widespread adoption of POC devices?

Reasons to buy

- “What Do Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table of Contents
for Point of Care Diagnostics - US Analysis and Market Forecasts

  • 1 Table of Contents

    1.1 List of Tables

    1.2 List of Figures

    2 Executive Summary

    2.1 Sales for the POC Diagnostics Market

    2.2 Market Dynamics

    2.3 Key Players in the POC Diagnostics Market

    2.4 POC Diagnostics Market Future Outlook

    2.5 What Do Physicians Think?

    3 Introduction

    3.1 Catalyst

    3.2 Related Reports

    4 Industry Overview

    4.1 POC Diagnostics Overview

    4.2 Test Trends

    4.2.1 Cardiac Markers POC Testing

    4.2.2 Female Fertility and Pregnancy POC Testing

    4.3 Mergers, Acquisitions, and Key Partnerships

    5 Unmet Needs

    5.1 Detection of Multiple Analytes

    5.2 Sensitivity of Lateral Flow Technology

    5.3 Analytical Quality

    5.4 Markers for Myocardial Ischemia

    5.5 Data Management

    5.6 POC Diagnostics to Reduce Usage of Antibiotics

    5.7 Cost-Effectiveness and Reimbursement

    5.8 Gap between Physicians and Manufacturers

    6 Market Drivers and Barriers

    6.1 Drivers

    6.1.1 Fast Turnaround Time

    6.1.2 POC Molecular Testing Driving Infectious Disease POCT

    6.1.3 Increasing Adoption of Cardiac Marker POCT

    6.1.4 Expansion POC Testing Menu

    6.1.5 Expansion of the Home-Testing Market

    6.1.6 CLIA Waived Status for POCT

    6.1.7 Rising Prevalence of Diseases

    6.2 Barriers

    6.2.1 Management of POCT

    6.2.2 Competition with Laboratory Tests

    6.2.3 Regulatory Compliance

    6.2.4 Medical Device Excise Tax

    7 Competitive Assessment

    7.1 Company Share Analysis

    7.1.1 US

    7.2 Trends in Corporate Strategy

    7.3 Major Players

    7.3.1 Abbott Diagnostics

    7.3.2 Akers Bioscience

    7.3.3 Alere

    7.3.4 Beckman Coulter

    7.3.5 BioMerieux

    7.3.6 Chembio Diagnostics

    7.3.7 EKF Diagnostics

    7.3.8 Meridian Bioscience

    7.3.9 OraSure Technologies

    7.3.10 Quidel

    7.3.11 Radiometer Medical

    7.3.12 Response Biomedical

    7.3.13 Roche Diagnostics

    7.3.14 Siemens Healthcare

    7.3.15 Trinity Biotech

    7.3.16 Other Companies

    8 Pipeline Assessment

    8.1 Overview

    8.2 Pipeline Profiles

    8.2.1 Cardiac Markers POCT

    8.2.2 Female Fertility and Pregnancy POCT

    8.2.3 Hematology POCT

    8.2.4 Infectious Disease POCT

    8.2.5 Immunochemistry POCT Analyzers

    9 Market Outlook

    9.1 US

    9.1.1 Overview

    9.1.2 Market Analysis

    10 Appendix

    10.1 Bibliography

    10.2 Abbreviations

    10.3 Report Methodology

    10.3.1 Overview

    10.3.2 Coverage

    10.3.3 Secondary Research

    10.3.4 Forecasting Methodology

    10.3.5 Primary Research — Key Opinion Leader Interviews

    10.3.6 Primary Research - Physician and Industry Interviews

    10.3.7 Expert Panel Validation

    10.4 Physicians and Specialists Included in This Study

    10.5 About the Authors

    10.5.1 Analysts

    10.5.2 Tyler Fletcher, Global Head of Medical Devices

    10.6 About MediPoint

    10.7 About GlobalData

    10.8 Contact Us

    10.9 Disclaimer

List Of Tables
in Point of Care Diagnostics - US Analysis and Market Forecasts

1.1 List of Tables

Table 1: POC Diagnostics: Key Metrics in the US, 2015-2021

Table 2: Advantages and Disadvantages of POCT

Table 3: US Troponin POCT Volume (thousands) Forecast, 2012-2021

Table 4: US B-type Natriuretic Peptide POCT Volume (thousands) Forecast, 2012-2021

Table 5: US Follicle-Stimulating Hormone POCT Volume Forecast, 2012-2021

Table 6: US Luteinizing Hormone POCT Volume (thousands) Forecast, 2012-2021

Table 7: US Human Chorionic Gonadotropin POCT Volume (thousands) Forecast, 2012-2021

Table 8: Mergers, Acquisitions, and Key Partnerships, 2012-2016

Table 9: Company Profile - Abbott Diagnostics

Table 10: Abbott Diagnostics’ POC Portfolio Assessment, 2015

Table 11: SWOT Analysis - Abbott Diagnostics

Table 12: Company Profile - Akers Bioscience

Table 13: Aker Bioscience’s POC Portfolio Assessment, 2015

Table 14: SWOT Analysis - Akers Bioscience

Table 15: Company Profile - Alere

Table 16: Alere’s POC Portfolio Assessment, 2015

Table 17: SWOT Analysis - Alere

Table 18: Company Profile - Beckman Coulter

Table 19: Beckman Coulter’s POC Portfolio Assessment, 2015

Table 20: SWOT Analysis - Beckman Coulter

Table 21: Company Profile - BioMerieux

Table 22: BioMerieux’s POC Portfolio Assessment, 2015

Table 23: SWOT Analysis - BioMerieux

Table 24: Company Profile - Chembio Diagnostics

Table 25: Chembio Diagnostics’ POC Portfolio Assessment, 2015

Table 26: SWOT Analysis - Chembio Diagnostics

Table 27: Company Profile - EKF Diagnostics

Table 28: EKF Diagnostics’ POC Portfolio Assessment, 2015

Table 29: SWOT Analysis - EKF Diagnostics

Table 30: Company Profile - Meridian Bioscience

Table 31: Meridian Bioscience’s POC Portfolio Assessment, 2015

Table 32: SWOT Analysis - Meridian Bioscience

Table 33: Company Profile - OraSure Technologies

Table 34: OraSure Technologies’ POC Portfolio Assessment, 2015

Table 35: SWOT Analysis - OraSure Technologies

Table 36: Company Profile - Quidel

Table 37: Quidel’s POC Portfolio Assessment, 2015

Table 38: SWOT Analysis - Quidel

Table 39: Company Profile - Radiometer Medical

Table 40: Radiometer Medical’s POC Portfolio Assessment, 2015

Table 41: SWOT Analysis - Radiometer Medical

Table 42: Company Profile - Response Biomedical

Table 43: Response Biomedical’s POC Portfolio Assessment, 2015

Table 44: SWOT Analysis - Response Biomedical

Table 45: Company Profile - Roche Diagnostics

Table 46: Roche Diagnostics’ POC Portfolio Assessment, 2015

Table 47: SWOT Analysis - Roche Diagnostics

Table 48: Company Profile - Siemens Healthcare

Table 49: Siemens Healthcare’s POC Portfolio Assessment, 2015

Table 50: SWOT Analysis - Siemens Healthcare

Table 51: Company Profile - Trinity Biotech

Table 52: Trinity Biotech’s POC Portfolio Assessment, 2015

Table 53: SWOT Analysis - Trinity Biotech

Table 54: Other POC Companies in North America, 2015

Table 55: Other POC Companies in Europe, 2015

Table 56: Other POC Companies in APAC and Other Regions, 2015

Table 57: Key Cardiac Markers POCT Pipelines, 2015

Table 58: Key Female Fertility and Pregnancy POCT Pipelines, 2015

Table 59: Key Hematology POCT Pipelines, 2015

Table 60: Key Infectious Disease POCT Pipelines, 2015

Table 61: Key Immunochemistry POCT Analyzer Pipelines, 2015

Table 62: US POC Diagnostics Sales Forecast ($m), 2012-2021

Table 63: POC Diagnostics - Primary Call Count

List Of Figures, Charts and Diagrams
in Point of Care Diagnostics - US Analysis and Market Forecasts

1.2 List of Figures

Figure 1: POC Diagnostics Market Revenue, US, 2015 and 2021

Figure 2: Troponin POCT Volume, 2012-2021

Figure 3: B-type Natriuretic Peptide POCT Volume, 2012-2021

Figure 4: Follicle-Stimulating Hormone POCT Volume, 2012-2021

Figure 5: Luteinizing Hormone POCT Volume, 2012-2021

Figure 6: Human Chorionic Gonadotropin POCT Volume, 2012-2021

Figure 7: US POC Diagnostics Market, By Company Share, 2015

Figure 8: US POC Diagnostics Sales Forecast ($m), 2012-2021

Figure 9: US POC Diagnostics Market Revenue Breakdown, by Segment, 2015

Figure 10: POC Diagnostics - Primary Call Count (N=390)

Additional Details

Publisher

Global Data

Publisher Information

Reference

27850 | GDME1186CFR

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Caplin Point Laboratories Ltd (CAPLIPOINT) - Financial and Strategic SWOT Analysis Review
SummaryCaplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures oi...
11 Jul 2016 by Global Data USD $300 More Info
Caplin Point Laboratories Ltd (CAPLIPOINT) - Financial and Strategic SWOT Analysis Review
SummaryCaplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures oi...
15 Apr 2016 by Global Data USD $300 More Info
MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts
MediPoint: Point of Care Diagnostics - Global Analysis and Market ForecastsSummaryPoint-of-care test...
01 Mar 2016 by Global Data USD $5,995 More Info
Point of Care Diagnostics - Current and Future Players
Point of Care Diagnostics - Current and Future PlayersSummaryThe Point-Of-Care (POC) market is very ...
01 Mar 2016 by Global Data USD $3,500 More Info
Point of Care Diagnostics - US Analysis and Market Forecasts
Point of Care Diagnostics - US Analysis and Market ForecastsSummaryThe US Point-Of-Care (POC) diagno...
01 Mar 2016 by Global Data USD $4,450 More Info
Point of Care Diagnostics - 5EU Analysis and Market Forecasts
Point of Care Diagnostics - 5EU Analysis and Market ForecastsSummaryThe Europe Point-Of-Care (POC) d...
01 Mar 2016 by Global Data USD $4,450 More Info
Point of Care Diagnostics - APAC Analysis and Market Forecasts
Point of Care Diagnostics - APAC Analysis and Market ForecastsSummaryThe Asia-Pacific (APAC) Point-O...
01 Mar 2016 by Global Data USD $4,450 More Info
Point of Care Diagnostics - South American Analysis and Market Forecasts
Point of Care Diagnostics - South American Analysis and Market ForecastsSummaryThe South America Poi...
01 Mar 2016 by Global Data USD $4,450 More Info
Caplin Point Laboratories Ltd (CAPLIPOINT) - Financial and Strategic SWOT Analysis Review
SummaryCaplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures oi...
09 Jan 2016 by Global Data USD $300 More Info
Caplin Point Laboratories Ltd (CAPLIPOINT) - Financial and Strategic SWOT Analysis Review
SummaryCaplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures oi...
08 Nov 2015 by Global Data USD $300 More Info

This report is published by Global Data

Download Free Report Summary PDF

Point of Care Diagnostics - US Analysis and Market Forecasts | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...